Suppr超能文献

一种中和性单克隆抗体对人免疫缺陷病毒1型共受体的功能模拟

Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.

作者信息

Xiang Shi-Hua, Farzan Michael, Si Zhihai, Madani Navid, Wang Liping, Rosenberg Eric, Robinson James, Sodroski Joseph

机构信息

Jimmy Fund Building, Room 824, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA.

出版信息

J Virol. 2005 May;79(10):6068-77. doi: 10.1128/JVI.79.10.6068-6077.2005.

Abstract

Interaction of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein with the primary receptor, CD4, promotes binding to a chemokine receptor, either CCR5 or CXCR4. The chemokine receptor-binding site on gp120 elicits CD4-induced (CD4i) antibodies in some HIV-1-infected individuals. Like CCR5 itself, the CD4i antibody 412d exhibits a preference for CCR5-using HIV-1 strains and utilizes sulfated tyrosines to achieve binding to gp120. Here, we show that 412d binding requires the gp120 beta19 strand and the base of the V3 loop, elements that are important for the binding of the CCR5 N terminus. Two gp120 residues in the V3 loop base determined 412d preference for CCR5-using HIV-1 strains. A chimeric molecule in which the 412d heavy-chain third complementarity-determining loop sequence replaces the CCR5 N terminus functioned as an efficient second receptor, selectively supporting the entry of CCR5-using HIV-1 strains. Sulfation of N-terminal tyrosines contributed to the function of this chimeric receptor. These results emphasize the close mimicry of the CCR5 N terminus by the gp120-interactive region of a naturally elicited CD4i antibody.

摘要

人类免疫缺陷病毒1型(HIV-1)的包膜糖蛋白gp120与主要受体CD4相互作用,促进其与趋化因子受体CCR5或CXCR4的结合。gp120上的趋化因子受体结合位点在一些感染HIV-1的个体中可引发CD4诱导(CD4i)抗体。与CCR5本身一样,CD4i抗体412d对使用CCR5的HIV-1毒株表现出偏好,并利用硫酸化酪氨酸实现与gp120的结合。在此,我们表明412d的结合需要gp120的β19链和V3环基部,这些元件对于CCR5 N末端的结合很重要。V3环基部的两个gp120残基决定了412d对使用CCR5的HIV-1毒株的偏好。一种嵌合分子,其中412d重链的第三个互补决定环序列取代了CCR5 N末端,起到了有效的第二受体的作用,选择性地支持使用CCR5的HIV-1毒株的进入。N末端酪氨酸的硫酸化有助于这种嵌合受体的功能。这些结果强调了天然诱导的CD4i抗体的gp120相互作用区域对CCR5 N末端的紧密模拟。

相似文献

引用本文的文献

5
Harnessing the protective potential of HIV-1 neutralizing antibodies.利用HIV-1中和抗体的保护潜力。
F1000Res. 2016 Jan 5;5. doi: 10.12688/f1000research.7254.1. eCollection 2016.
6
HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.作为治疗靶点的HIV-1 gp120:在动态迷宫中探索
Expert Opin Ther Targets. 2015 Jun;19(6):765-83. doi: 10.1517/14728222.2015.1010513. Epub 2015 Feb 27.
9
Candidate antibody-based therapeutics against HIV-1.针对 HIV-1 的候选抗体类治疗药物。
BioDrugs. 2012 Jun 1;26(3):143-62. doi: 10.2165/11631400-000000000-00000.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验